
prostate cancer | Medivizor | source: Medivizor | Added Aug 15, 2021
Oncology Basics 2016: DNA


prostate cancer | Medivizor | source: Medivizor | Added Aug 08, 2021
Positive Thinking and Cancer-Myth-Making


prostate cancer | Medivizor | source: Medivizor | Added Aug 06, 2021
Oncology Basics 2016: Genes and Cancer Treatment


prostate cancer | Medivizor | source: Medivizor | Added Aug 04, 2021
Oncology Basics 2016: The Immune System and Immunotherapy


prostate cancer | Medivizor | source: Medivizor | Added Jul 30, 2021
15 Tips to Cope with Scanxiety (Scan Anxiety)


prostate cancer | Medivizor | source: Medivizor | Added Jul 26, 2021
Cancer Patient Resources: Free Air Travel



prostate cancer | Research | Treatment | 10 pages | source: International journal of radiation oncology, biology, physics | Added Jul 24, 2021
Evaluating hypofractionated radiotherapy after prostate surgery in patients with prostate cancer.
This study investigated the outcomes of hypofractionated intensity-modulated radiation therapy (H-IMRT) to the prostate bed in patients with localized prostate cancer after prostate surgery. The data showed that H-IMRT after prostate surgery was safe and well-tolerated in these patients.


prostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Jul 17, 2021
Comparing docetaxel to abiraterone in patients with metastatic castration-sensitive prostate cancer
This study compared the effectiveness of docetaxel (DOC; Taxotere) to abiraterone (ABI; Zytiga) and assessed possible predictive markers of progression-free survival (PFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC). The authors concluded that under real-world conditions, ABI was associated with better PFS in these patients.

prostate cancer | Research | 10 pages | source: Cancer | Added Jul 15, 2021
Does androgen-deprivation therapy increase risk of mortality from heart attack or stroke?
This study examined the risk of heart-related mortality in patients undergoing androgen-deprivation therapy (ADT) for prostate cancer. It found that patients treated with radiation therapy and ADT did not have an increased risk of heart-related mortality.

prostate cancer | Medivizor | source: Medivizor | Added Jul 10, 2021
What Should You Ask Your Doctor About Your Cancer Diagnosis?
